Literature DB >> 21761334

Functional significance of Aurora kinase A regulatory interactions with p53-ERα complex in human breast cancer cells.

Hiroshi Katayama1, Subrata Sen.   

Abstract

Aurora kinase A (Aurora-A), a proto-oncogenic mitosis-regulating serine/threonine kinase, is frequently overexpressed in human breast cancer. While the kinase has been shown to cause functional inactivation of tumor suppressor protein p53, which binds estrogen receptor α (ERα) and downregulates its transcriptional activation function, significance of Aurora-A overexpression on p53 regulatory interactions in breast cancer cells has not been investigated. We describe in this report functional consequences of Aurora-A phosphorylation of p53 tumor suppressor protein on its subcellular distribution and binding with ERα that may be important in downregulating the transcription of p53-responsive growth inhibitory genes and development of resistance to DNA damage-induced apoptosis in Aurora-A overexpressing human breast cancer cells. Our results demonstrate that while estrogen activates Aurora-A expression in ERα-positive cells through ERα-GATA-3 signaling cascade, Aurora-A forms a ternary complex with p53 and ERα. Phosphorylation of p53 by Aurora-A sequesters the protein in the cytoplasm and enhances its interaction with ERα, thus repressing the transactivation functions of both p53 and ERα. These findings have significant clinical implications and suggest that prolonged estrogen exposure-mediated Aurora-A overexpression may be directly contributing to deregulated proliferation and resistance to DNA damage-induced apoptosis in breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21761334     DOI: 10.1007/s12672-011-0070-x

Source DB:  PubMed          Journal:  Horm Cancer        ISSN: 1868-8497            Impact factor:   3.869


  28 in total

1.  Polymorphisms of the AURKA (STK15/Aurora Kinase) Gene and Breast Cancer Risk (United States).

Authors:  David G Cox; Susan E Hankinson; David J Hunter
Journal:  Cancer Causes Control       Date:  2006-02       Impact factor: 2.506

2.  A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers.

Authors:  J R Bischoff; L Anderson; Y Zhu; K Mossie; L Ng; B Souza; B Schryver; P Flanagan; F Clairvoyant; C Ginther; C S Chan; M Novotny; D J Slamon; G D Plowman
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

3.  An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival.

Authors:  Lance D Miller; Johanna Smeds; Joshy George; Vinsensius B Vega; Liza Vergara; Alexander Ploner; Yudi Pawitan; Per Hall; Sigrid Klaar; Edison T Liu; Jonas Bergh
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-02       Impact factor: 11.205

4.  Interaction and feedback regulation between STK15/BTAK/Aurora-A kinase and protein phosphatase 1 through mitotic cell division cycle.

Authors:  H Katayama; H Zhou; Q Li; M Tatsuka; S Sen
Journal:  J Biol Chem       Date:  2001-09-10       Impact factor: 5.157

Review 5.  Defining the steps in a multistep mouse model for mammary carcinogenesis.

Authors:  H E Varmus; L A Godley; S Roy; I C Taylor; L Yuschenkoff; Y P Shi; D Pinkel; J Gray; R Pyle; C M Aldaz
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1994

6.  Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast.

Authors:  T Tanaka; M Kimura; K Matsunaga; D Fukada; H Mori; Y Okano
Journal:  Cancer Res       Date:  1999-05-01       Impact factor: 12.701

7.  Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation.

Authors:  Santhi D Konduri; Rajesh Medisetty; Wensheng Liu; Benny Abraham Kaipparettu; Pratima Srivastava; Hiltrud Brauch; Peter Fritz; Wendy M Swetzig; Amanda E Gardner; Sohaib A Khan; Gokul M Das
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-09       Impact factor: 11.205

8.  Estrogen receptor-alpha binds p53 tumor suppressor protein directly and represses its function.

Authors:  Wensheng Liu; Santhi D Konduri; Sanjay Bansal; Bijaya K Nayak; Sigrid A Rajasekaran; Sankunny M Karuppayil; Ayyappan K Rajasekaran; Gokul M Das
Journal:  J Biol Chem       Date:  2006-02-09       Impact factor: 5.157

9.  Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.

Authors:  Aejaz Sayeed; Santhi D Konduri; Wensheng Liu; Sanjay Bansal; Fengzhi Li; Gokul M Das
Journal:  Cancer Res       Date:  2007-08-15       Impact factor: 12.701

10.  Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets.

Authors:  Katherine J Martin; Denis R Patrick; Mina J Bissell; Marcia V Fournier
Journal:  PLoS One       Date:  2008-08-20       Impact factor: 3.240

View more
  5 in total

Review 1.  Tumor suppressor p53 and estrogen receptors in nuclear-mitochondrial communication.

Authors:  Nadi T Wickramasekera; Gokul M Das
Journal:  Mitochondrion       Date:  2013-10-29       Impact factor: 4.160

2.  Aurora B prevents delayed DNA replication and premature mitotic exit by repressing p21(Cip1).

Authors:  Marianna Trakala; Gonzalo Fernández-Miranda; Ignacio Pérez de Castro; Christopher Heeschen; Marcos Malumbres
Journal:  Cell Cycle       Date:  2013-02-21       Impact factor: 4.534

3.  Aurora kinase-A overexpression in mouse mammary epithelium induces mammary adenocarcinomas harboring genetic alterations shared with human breast cancer.

Authors:  Warapen Treekitkarnmongkol; Hiroshi Katayama; Kazuharu Kai; Kaori Sasai; Jennifer Carter Jones; Jing Wang; Li Shen; Aysegul A Sahin; Mihai Gagea; Naoto T Ueno; Chad J Creighton; Subrata Sen
Journal:  Carcinogenesis       Date:  2016-09-13       Impact factor: 4.944

4.  A comprehensive analysis of Aurora A; transcript levels are the most reliable in association with proliferation and prognosis in breast cancer.

Authors:  Satoko Yamamoto; Mutsuko Yamamoto-Ibusuki; Yutaka Yamamoto; Saori Fujiwara; Hirotaka Iwase
Journal:  BMC Cancer       Date:  2013-04-30       Impact factor: 4.430

5.  Aurora-A/SOX8/FOXK1 signaling axis promotes chemoresistance via suppression of cell senescence and induction of glucose metabolism in ovarian cancer organoids and cells.

Authors:  Huizhen Sun; Husheng Wang; Xue Wang; Yoichi Aoki; Xinjing Wang; Yufei Yang; Xi Cheng; Ziliang Wang; Xipeng Wang
Journal:  Theranostics       Date:  2020-05-25       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.